There is a race going on to lower the cost human gene sequencing to a level of a comprehensive battery of blood tests.
The winners stand to make handsome profits while changing the face of medicine. How can an investor or trader get in on any eventual profits?
Can there be stock options profits from low cost gene sequencing?
Buying puts or calls on stocks gives the options trader the right to sell (with puts) or buy (with calls) an underlying stock but confers no obligation to do so.
With low priced contracts, buying options on a given stock can be a much more cost effective strategy than buying a stock or selling short.
The issue often hinges around timing and may require more than a passing familiarity with the biology and technology involved.
Several companies are racing to perfect a variety of approaches to fast and efficient sequencing gene sequencing. In order to gain stock options profits from low cost gene sequencing the trader needs to go back to school a little.
The Human Genome
It was only half a century ago that Crick and Watson discovered the helical structure of DNA.
Over the years, knowledge of DNA, human genes, what genes do and how they cause or cure diseases has grown exponentially.
The human genome is the sum total of all human genes.
Human genes are present on long strands of DNA (complex molecules) called chromosomes.
These strands are paired, connected side to side along their lengths. Humans have 23 pairs of chromosomes.
Some parts of the DNA strands appear to be inert while others are rich in genes.
These genes produce proteins which in turn carry out a large variety of often complex functions in the human body.
Understanding just how genes produce proteins and what these proteins do has been the increasingly successful job of scientists for years.
Having a sense of the medical products and therapies that can come from this research can lead to stock options profits from low cost gene sequencing and other advances in the field of biotechnology.
Gene Sequencing, Cures for Genetic Diseases, and More
The human genome contains roughly 23,000 pairs of proteins that code or produce proteins. Gene sequencing allows scientists to map a chromosome.
The field is moving so fast that it is now possible to map the genes of an individual person’s DNA for not much more than $5,000 at Complete Genomics - GNOM, a Silicon Valley high tech company.
The stated goal of several competing companies is to lower to cost to below $1,000 a test. Other leaders in this field include Life Technologies - LIFE, and Oxford Nanopore Technologies, a private UK company.
Stock options profits from low cost gene sequencing will come to those who understand the fundamentals of what these companies are trying to do and the potential profits when the technology is readily available.
World Economic Forum : The Global Risks Report 2024
Stock Options Profits from Low Cost Gene Sequencing
1. Stock Options Profits from Low
Cost Gene Sequencing
www.Options-Trading-Education.com
2. To see a complete version of this presentation and to obtain
our free EBook follow this link:
http://portal.sliderocket.com/BLOUC/Compare-Stock-
Earnings-to-Stock-Price
Read the Forex Conspiracy Report for insights into trading
foreign currencies. Get your copy at
http://portal.sliderocket.com/BLOUC/Compare-Stock-
Earnings-to-Stock-Price
www.Options-Trading-Education.com
3. There is a race going on to lower the cost human
gene sequencing to a level of a comprehensive
battery of blood tests.
www.Options-Trading-Education.com
4. The winners stand to make handsome profits while
changing the face of medicine. How can an investor
or trader get in on any eventual profits?
www.Options-Trading-Education.com
5. Can there be stock options profits from low cost
gene sequencing?
www.Options-Trading-Education.com
6. Buying puts or calls on stocks gives the options
trader the right to sell (with puts) or buy (with calls)
an underlying stock but confers no obligation to do
so.
www.Options-Trading-Education.com
7. With low priced contracts, buying options on a given
stock can be a much more cost effective strategy
than buying a stock or selling short.
www.Options-Trading-Education.com
8. The issue often hinges around timing and may
require more than a passing familiarity with the
biology and technology involved.
www.Options-Trading-Education.com
9. Several companies are racing to perfect a variety of
approaches to fast and efficient sequencing gene
sequencing. In order to gain stock options profits
from low cost gene sequencing the trader needs to
go back to school a little.
www.Options-Trading-Education.com
10. The Human Genome
It was only half a century ago that Crick and Watson
discovered the helical structure of DNA.
www.Options-Trading-Education.com
11. Over the years, knowledge of DNA, human
genes, what genes do and how they cause or cure
diseases has grown exponentially.
www.Options-Trading-Education.com
12. The human genome is the sum total of all human
genes.
Human genes are present on long strands of DNA
(complex molecules) called chromosomes.
www.Options-Trading-Education.com
13. These strands are paired, connected side to side
along their lengths. Humans have 23 pairs of
chromosomes.
www.Options-Trading-Education.com
14. Some parts of the DNA strands appear to be inert
while others are rich in genes.
These genes produce proteins which in turn carry
out a large variety of often complex functions in the
human body.
www.Options-Trading-Education.com
15. Understanding just how genes produce proteins and
what these proteins do has been the increasingly
successful job of scientists for years.
www.Options-Trading-Education.com
16. Having a sense of the medical products and
therapies that can come from this research can lead
to stock options profits from low cost gene
sequencing and other advances in the field of
biotechnology.
www.Options-Trading-Education.com
17. Gene Sequencing, Cures for Genetic Diseases, and
More
The human genome contains roughly 23,000 pairs of
proteins that code or produce proteins. Gene
sequencing allows scientists to map a chromosome.
www.Options-Trading-Education.com
18. The field is moving so fast that it is now possible to
map the genes of an individual person’s DNA for not
much more than $5,000 at Complete Genomics -
GNOM, a Silicon Valley high tech company.
www.Options-Trading-Education.com
20. The stated goal of several competing companies is
to lower to cost to below $1,000 a test. Other
leaders in this field include Life Technologies - LIFE,
and Oxford Nanopore Technologies, a private UK
company.
www.Options-Trading-Education.com
21. Stock options profits from low cost gene sequencing
will come to those who understand the
fundamentals of what these companies are trying to
do and the potential profits when the technology is
readily available.
www.Options-Trading-Education.com
22. Stock Options Profits from Low Cost Gene
Sequencing
Science provides us with lots of startling discoveries.
However, the ability to see a practical use for a
discovery is a different thing.
www.Options-Trading-Education.com
23. The ability to take and shape existing technologies,
cost effectively is a skill in and of itself.
www.Options-Trading-Education.com
24. Then there is the matter of marketing a product and
beating the competition. For products that have
medical applications there is the long process of
gaining approval from the US Food and Drug
Administration by demonstrating that a new
product or treatment does not hurt anyone and
brings about significant improvement or cure of a
condition.
www.Options-Trading-Education.com
25. To gain profits from low cost gene sequencing
companies need to do more than just develop a
new technology.
www.Options-Trading-Education.com
26. Investors need to avoid being dazzled by high tech
and look for potential profits.
www.Options-Trading-Education.com
27. For more insights and useful information regarding
options and options trading, visit www.Options-
Trading-Education.com.